Segment Information (Tables)

12 Months Ended

Dec. 31, 2021

Segment Reporting [Abstract]

Schedule of segment information

	Cannabis and Medical Marijuana Segment			Facilities Operations Related			Corporate, Other, and Eliminations			Consolidated
2021
Net sales	$	40,764		$	5,969,674		$	-		$	6,010,438
Operating income (loss)		26,849			95,336			(526,521	)		(404,336	)
Interest income		-			3			70,226			70,229
Interest expense		-			38,330			24,062			62,392
Total assets		900,484			2,240,047			1,645,910			4,786,441
Property additions		-			160,102			1,264			161,366
Fixed asset depreciation and amortization		-			45,936			5,744			51,710
2020
Net sales	$	47,707		$	4,778,249		$	-		$	4,825,956
Operating income (loss)		(13,258	)		(231,162	)		(829,684	)		(1,074,104	)
Interest income		-			-			92,571			92,571
Interest expense		-			34,711			584			35,295
Total assets		1,042,553			1,874,519			1,524,023			4,441,095
Property additions		-			126,396			7,593			133,989
Fixed asset depreciation and amortization		-			20,553			7,103			27,656

Reconciliation of revenue from segments to consolidated

The following table reconciles operating segments and corporate-unallocated operating income (loss) to consolidated income before income taxes for the years ended December 31, 2021 and 2020, as presented in the consolidated income statements:

	2021			2020
Operating loss	$	(404,336	)	$	(1,074,104	)
Realized gain (loss) on investments in securities		1,017			(14,961	)
Gain on sale of GlauCanna rights		-			31,000
Impairment of investments		22,718			(139,148	)
Interest income		70,229			92,571
Interest expense		(62,392	)		(35,295	)
Gain (loss) on equipment disposals		86			67
PPP loan forgiven		87,122			452,348
EIDL Grant		-			10,000
Other income		38,870			10,031
Income before income taxes	$	(246,686	)	$	(667,491	)